MAGNESIUM OXIDE 400MG- magnesium oxide 400mg tablet 
Spirit Pharmaceuticals LLC

----------

Magnesium Oxide Tablets

ACTIVE INGREDIENT (In each tablet)

Magnesium Oxide 400mg (241.3mg elemental magnesium)

Purpose

Antacid

USES

relieves

WARNINGS

Ask a doctor if you have

kidney disease

Ask a doctor or pharmacist before use if you are

taking a prescription drug. Antacids may interact with certain prescription drugs.

Do not take

more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advise and supervision of a physician. May have a laxative effect.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

Keep out of reach of children.

DIRECTIONS

OTHER INFORMATION

INACTIVE INGREDIENTS

colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, stearic acid

Questions or comments?

1-888-333-9792

PDP

Cabinet:

Antacid

Magnesium Oxide 400mg

75 Tablets

image description

MAGNESIUM OXIDE 400MG 
magnesium oxide 400mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68210-4105
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code 174
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68210-4105-175 in 1 BOTTLE; Type 0: Not a Combination Product07/02/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00107/02/2020
Labeler - Spirit Pharmaceuticals LLC (179621011)

Revised: 12/2023
Document Id: 0bf02249-f336-3752-e063-6394a90a171e
Set id: 395601f7-a8e8-48d8-b1e0-7fad496ef461
Version: 4
Effective Time: 20231207
 
Spirit Pharmaceuticals LLC